We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Raises Offer, Buys Remaining Stake in Chiron
Novartis Raises Offer, Buys Remaining Stake in Chiron
November 4, 2005
After being spurned by Chiron six weeks ago, Novartis has agreed to pay $5.1 billion to acquire full control of the California-based drugmaker — a move that significantly boosts its presence in the red-hot vaccines market.